Norway has been a global frontrunner in collecting health data and building unique registries for decades but has struggled to utilise and benefit…

The latest from Spanish pharma, including the Patent and Trademark Office’s warning of the importance of IP protection for medical advancements,…

Equality has long been a deeply held ideal in Norway, where the concept of allemannsretten – the legal right to roam – permeates all aspects of…

The latest from Spanish pharma, including the wide swathe of COVID-19 syringes, vaccines, masks, and tests being produced in the country, Grifols’…

Small in terms of market size and without the historic life sciences footprint of neighbouring Sweden and Denmark, Norway nevertheless has excellent…

Karita Bekkemellem of Norwegian pharma association LMI highlights her work building up the profile of the industry in Norway, the market access and…

Rui Ferreira Dos Santos, country manager for Spanish pharmaceutical company, Almirall provides readers with an update on the company’s new medicines…

Dwight Gorham, president and CEO of Pillar5 Pharma, discusses the unique positioning of the CDMO in the multi-dose preservative free sterile…

Riccardo Palmisano, CEO of MolMed, discusses the latest developments for their late-stage clinical development products, and comments on the recent…

Having successfully accomplished a four-year turnaround exercise and with a fresh capital injection from a leading Italian PE firm, SIFI executive…

The pharmaceutical industry needs to work harder to demonstrate the value that it delivers to society and to the greater economy by advancing public…

Almirall Portugal stopped all commercial activity in 2011 to focus only on the market access of new, innovative products being introduced through the…